Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 12:50 pm Purchase | 2024-11-01 | 13G | ESSA Pharma Inc. EPIX | BML Investment Partners, L.P. | 4,183,223 9.400% | 4,183,223 (New Position) | Filing History |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,262,500 7.400% | -581,832 (-15.13%) | Filing History |
| 2024-02-14 07:05 am Purchase | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 2,298,662 5.200% | 2,298,662 (New Position) | Filing History |
| 2024-02-13 06:04 am Unchanged | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | BB BIOTECH AG | 7,879,583 17.900% | 0 (Unchanged) | Filing History |
| 2024-02-08 11:29 am Purchase | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | MORGAN STANLEY MS | 4,186,578 9.500% | 4,186,578 (New Position) | Filing History |
| 2024-01-23 4:09 pm Purchase | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | Soleus Capital Special Opportunities Fund, L.P. | 4,327,622 9.800% | 458,230 (+11.84%) | Filing History |
| 2023-02-14 4:12 pm Purchase | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | BB BIOTECH AG | 7,879,583 17.900% | 2,863,769 (+57.09%) | Filing History |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | Soleus Capital Special Opportunities Fund, L.P. | 3,869,392 8.800% | 3,869,392 (New Position) | Filing History |
| 2023-02-14 3:52 pm Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | Avidity Partners Management LP | 1,855,400 4.200% | -1,894,600 (-50.52%) | Filing History |
| 2023-02-14 2:50 pm Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | Eventide Asset Management, LLC | 0 0.000% | -3,318,647 (Position Closed) | Filing History |
| 2023-02-14 10:04 am Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 0 0.000% | -2,637,192 (Position Closed) | Filing History |
| 2023-02-09 10:37 am Sale | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -3,404,707 (Position Closed) | Filing History |
| 2022-11-10 4:02 pm Purchase | 2022-10-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 3,844,332 (New Position) | Filing History |
| 2022-10-27 09:56 am Purchase | 2022-10-26 | 13G | ESSA Pharma Inc. EPIX | Avidity Partners Management LP | 3,750,000 8.500% | 3,750,000 (New Position) | Filing History |
| 2022-07-12 4:40 pm Purchase | 2022-07-08 | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.900% | 4,183,387 (+91.64%) | Filing History |
| 2022-02-14 1:43 pm Purchase | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | BIOTECHNOLOGY VALUE FUND L P | 4,565,242 9.990% | 859,953 (+23.21%) | Filing History |
| 2022-02-14 11:46 am Purchase | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | Eventide Asset Management, LLC | 3,318,647 7.500% | 983,479 (+42.12%) | Filing History |
| 2022-02-14 08:46 am Sale | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | RTW Investments, LP | 2,637,192 6.000% | -391,527 (-12.93%) | Filing History |
| 2022-02-11 5:23 pm Purchase | 2021-12-31 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX, LLC | 624,902 1.400% | 624,902 (New Position) | Filing History |